Gefitinib Polisano

Gefitinib Polisano is an oral medication used to treat certain types of cancer. It works by targeting specific proteins in cancer cells to slow their growth. Learn more about Gefitinib Polisano and its uses.

Gefitinib Polisano is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has spread or cannot be removed by surgery. It is designed to target and inhibit the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. This medication is often considered for patients with specific genetic mutations that make their cancer cells dependent on the EGFR protein.

Common effects of Gefitinib Polisano may include skin rash, diarrhea, and nausea. Some users may also experience fatigue, loss of appetite, or dry skin. These effects can vary in intensity and duration, and not everyone will experience them. It's important to monitor any changes and consult a healthcare provider if concerns arise.

Gefitinib Polisano should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication may interact with other treatments, so it's crucial to inform your healthcare provider about all medications you are taking. Always use Gefitinib Polisano under medical supervision.

Gefitinib Polisano may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. This can affect how well the medication works or increase the risk of side effects. It's important to discuss all current medications with a healthcare provider to avoid potential interactions. Additionally, certain foods and supplements may also interact with Gefitinib Polisano.